Karyopharm Therapeutics reported $302.69M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
AstraZeneca AZN:LN 27146M 1659M
Astrazeneca AZN:US 27.15B 1.66B
Avrobio Inc AVRO:US $ 15.1M 84K
Bristol Myers Squibb BMY:US $ 37107M 343M
Eli Lilly And LLY:US $ 14692M 460.9M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Epizyme EPZM:US $ 232.9M 411K
GlaxoSmithKline GSK:LN 18784M 10442M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 23784M 589M
Novartis NVS:US $ 23784M 589M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Takeda 4502:JP Y 4320357M 178939M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.16M 0.23M